What should you know about prostate cancer research?

Researchers study how prostate tumours begin, grow, and respond to treatment. Areas may include blood and imaging tests, tissue analysis, inherited risk, tumour features, active monitoring, surgery, radiotherapy, medicines, and care for cancer that has spread. A research result does not automatically change an individual plan; clinicians interpret it alongside examination findings, scans, biopsy information, other health conditions, and personal preferences.

Some studies evaluate ways to distinguish slow-growing disease from cancer that needs prompt treatment. Others investigate how to reduce treatment effects while protecting cancer control. You can read more about the condition on the Prostate Cancer page.

Ask whether a proposed test or treatment is established care, being evaluated in a clinical study, or available only in selected circumstances. Request the study’s purpose, eligibility requirements, possible burdens, alternatives, and follow-up arrangements in plain language. Research may relate to surgery such as Prostate Removal Surgery, radiotherapy, brachytherapy, or targeted radioisotope therapy, but suitability depends on the cancer’s location and behaviour.

Keep a record of pathology reports, scan results, medicines, and questions. This helps a specialist explain whether new evidence applies to your situation rather than to a different group of patients.

Research reading should not delay assessment of new or worsening symptoms. Contact a clinician promptly for difficulty passing urine, blood in urine, new bone pain, unexplained weakness, or pain that is severe or persistent. Seek urgent help if you cannot pass urine, develop sudden severe weakness, or become acutely unwell.

Which research findings are relevant to my biopsy, scans, and overall health? Is there a standard-care option and a study option? What would participation involve, and how would we monitor benefit or harm?